PT Metro Healthcare Indonesia Tbk - Laporan Laba Rugi (TTM)

PT Metro Healthcare Indonesia Tbk
ID ˙ IDX
Laporan Laba Rugi (TTM)

Laporan Laba Rugi PT Metro Healthcare Indonesia Tbk menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 198,330 216,296 234,686 258,201 289,798 290,934 278,751 257,336 230,153 260,426 251,761 254,536 260,242 242,681 271,522 301,357 308,717 319,022 315,185 311,611
Change (%) 9.06 8.50 10.02 12.24 0.39 -4.19 -7.68 -10.56 13.15 -3.33 1.10 2.24 -6.75 11.88 10.99 2.44 3.34 -1.20 -1.13
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 103,749 114,639 119,569 126,769 141,306 146,481 148,190 146,332 139,142 166,534 165,432 158,487 173,996 154,716 174,172 209,758 209,763 216,317 215,062 173,229
Change (%) 10.50 4.30 6.02 11.47 3.66 1.17 -1.25 -4.91 19.69 -0.66 -4.20 9.79 -11.08 12.58 20.43 0.00 3.12 -0.58 -19.45
% of Revenue 52.31 53.00 50.95 49.10 48.76 50.35 53.16 56.86 60.46 63.95 65.71 62.27 66.86 63.75 64.15 69.60 67.95 67.81 68.23 55.59
Gross Operating Profit 94,581 101,657 115,117 131,432 148,492 144,454 130,560 111,005 91,011 93,893 86,329 96,049 86,246 87,965 97,350 91,599 98,954 102,705 100,123 138,382
Change (%) 7.48 13.24 14.17 12.98 -2.72 -9.62 -14.98 -18.01 3.17 -8.06 11.26 -10.21 1.99 10.67 -5.91 8.03 3.79 -2.51 38.21
% of Revenue 47.69 47.00 49.05 50.90 51.24 49.65 46.84 43.14 39.54 36.05 34.29 37.73 33.14 36.25 35.85 30.40 32.05 32.19 31.77 44.41
SG&A 97,615 113,605 118,894 125,316 128,494 121,608 127,914 132,218 134,030 145,822 139,036 126,082 126,190 116,322 117,421 124,738 118,646 126,121 133,319 121,250
Change (%) 16.38 4.66 5.40 2.54 -5.36 5.19 3.37 1.37 8.80 -4.65 -9.32 0.09 -7.82 0.94 6.23 -4.88 6.30 5.71 -9.05
% of Revenue 49.22 52.52 50.66 48.53 44.34 41.80 45.89 51.38 58.24 55.99 55.23 49.53 48.49 47.93 43.25 41.39 38.43 39.53 42.30 38.91
R&D
Change (%)
% of Revenue
OpEx 203,273 231,813 241,828 252,567 273,875 276,836 285,163 289,579 285,002 321,018 313,718 292,326 307,881 278,820 298,696 341,457 336,584 348,950 355,745 303,152
Change (%) 14.04 4.32 4.44 8.44 1.08 3.01 1.55 -1.58 12.64 -2.27 -6.82 5.32 -9.44 7.13 14.32 -1.43 3.67 1.95 -14.78
% of Revenue 102.49 107.17 103.04 97.82 94.51 95.15 102.30 112.53 123.83 123.27 124.61 114.85 118.31 114.89 110.01 113.31 109.03 109.38 112.87 97.29
Operating Income -4,943 -15,517 -7,142 5,634 15,923 14,098 -6,413 -32,243 -54,849 -60,591 -61,958 -37,790 -47,640 -36,139 -27,173 -40,101 -27,867 -29,928 -40,560 8,460
Change (%) 213.91 -53.98 -178.88 182.66 -11.46 -145.49 402.79 70.11 10.47 2.25 -39.01 26.06 -24.14 -24.81 47.57 -30.51 7.39 35.53 -120.86
% of Revenue -2.49 -7.17 -3.04 2.18 5.49 4.85 -2.30 -12.53 -23.83 -23.27 -24.61 -14.85 -18.31 -14.89 -10.01 -13.31 -9.03 -9.38 -12.87 2.71
Interest Expense -13,240 -11,306 -11,227 -11,686 -14,617 -25,432 -42,713 -61,057 -76,920 -89,333 -89,750 -82,943 -88,452 -75,775 -73,478 -76,598 -70,050 -74,565 -70,944 -67,234
Change (%) -14.60 -0.70 4.09 25.08 73.99 67.95 42.95 25.98 16.14 0.47 -7.58 6.64 -14.33 -3.03 4.25 -8.55 6.45 -4.86 -5.23
% of Revenue -6.68 -5.23 -4.78 -4.53 -5.04 -8.74 -15.32 -23.73 -33.42 -34.30 -35.65 -32.59 -33.99 -31.22 -27.06 -25.42 -22.69 -23.37 -22.51 -21.58
Net Income 8,811 14,313 24,829 23,746 21,958 6,099 -25,135 -61,350 -92,420 -93,544 -104,203 -81,944 -104,612 -110,920 -100,908 -116,151 -89,386 -80,309 -87,232 -33,674
Change (%) 62.44 73.47 -4.36 -7.53 -72.22 -512.10 144.08 50.65 1.22 11.39 -21.36 27.66 6.03 -9.03 15.10 -23.04 -10.15 8.62 -61.40
% of Revenue 4.44 6.62 10.58 9.20 7.58 2.10 -9.02 -23.84 -40.16 -35.92 -41.39 -32.19 -40.20 -45.71 -37.16 -38.54 -28.95 -25.17 -27.68 -10.81

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista